RIGL20261218P31
RIGL Dec 18 2026 31.00 Put (RIGL261218P00031000)
option OPRA

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.